Evolving treatments and future therapeutic targets in desmoplastic melanoma
- PMID: 34900219
- PMCID: PMC8656346
- DOI: 10.2217/mmt-2020-0013
Evolving treatments and future therapeutic targets in desmoplastic melanoma
Keywords: cancer; desmoplastic; emerging; genetic markers; immunotherapies; melanoma; mutations; oncology; therapies; treatment.
Conflict of interest statement
Financial & competing interests disclosure The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.
References
-
- Feng Z, Wu X, Chen V, Velie E, Zhang Z. Incidence and survival of desmoplastic melanoma in the United States, 1992–2007. J. Cutan. Pathol. 38(8), 616–624 (2011). - PubMed
-
- Simionato C, Minaudo C, Mosquera T, Marini M, Saponaro A, Vigovich F. Mixed desmoplastic melanoma. Medicina (B Aires). 80(3), 280–284 (2020). - PubMed
Publication types
LinkOut - more resources
Full Text Sources